ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Aarti Drugs Ltd has submitted its quarterly shareholding pattern in compliance with Regulation 31(1)(b) of SEBI (LODR) Regulations for the quarter ended June 30, 2026.
Aarti Drugs Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.
Aarti Drugs Limited submitted a compliance certificate for the quarter ended March 31, 2026, regarding the dematerialisation of securities. The certificate, issued by MUFG Intime India, confirms that security certificates received were processed and listed on exchanges within prescribed timelines. This is a routine regulatory disclosure.
Aarti Drugs Ltd launched the 'Saksham Niveshak' campaign from April to July 2026, following MCA guidelines. The initiative encourages shareholders to update KYC details to claim unpaid dividends before they transfer to the IEPF. This improves investor relations and ensures compliance with dividend distribution regulations.